COMPLETION OF PILOT RENOVATIONS

The InQbation Lab completed the final phase of its pilot renovations in June. The pilot, which covers about 15,000 sq ft at 1801 Maple Ave in downtown Evanston, includes co-working stations, offices, and conference rooms as well as startup offices and wet labs across the 1st, 5th and 6th floors.

Q RESIDENT STARTUPS

With the completion of our pilot renovations, InQbation Lab is now home to 11 resident startups in both the physical and life sciences. These include Actinia, Volexion, Rhaeos, HemoRhythmics, Stemloop, Syenex, Opera Biosciences, MFNS-Tech, IP Studio, Skyway Biosciences, and Aplexis.

If you are NORTHWESTERN STARTUP with an active option or license and need space, apply to become a Q Resident HERE.

SUMMER VISITS AT THE Q

The InQbation Lab hosted Innovyz USA and General Inception this summer. Both firms are venture studios seeking to identify innovative technologies around which to build a founding team and inject financial resources for commercialization. Innovyz USA's focus is on sustainability and the circular economy. General Inception's interests range from synthetic biology, rare disease, and inflammation to general life science.

If you are NORTHWESTERN FACULTY and would like to participate in such meetings, speak with your Invention Manager at INVO to better understand the types and stage of technologies that are the best fit. We welcome your interest.

Volexion (Prof. Mark Hersam, McCormick) is raising $1.2M in their Seed- Series 2 funding from undisclosed investors with $250k open. They are continuing the development, scale-up and commercialization of their graphene encapsulation technology.

Flashpoint Therapeutics (Prof. Chad Mirkin, Weinberg) is actively subscribing a $10M round with a lead investor putting in $5M .

If you are a NORTHWESTERN STARTUP with an active option/license and would like to share fundraising or milestone news through this monthly newsletter, please email inqbationlab@northwestern.edu for consideration.

If you are an INVESTOR and are interested in receiving more information on these opportunities, please reach out to us at inqbationlab@northwestern.edu.

NM-Q MEDICAL DEVICE STUDIO

The NEW NM-Q Medical Device Studio is designed to enable clinicians (physicians, nurses or other healthcare providers) to move from "napkin drawings" to initial prototypes, facilitating initial conversations and interest among clinicians, industry partners and/or investors. The studio is supported by the Northwestern Medicine's Mansueto Innovation Institute and Northwestern's Querrey InQbation Lab.

Up to four (4) medical devices or tools will be selected. In collaboration with the clinician, NM-Q will engage with external prototyping firms to support the initial prototyping build. Up to $50k of funding will be allocated to each project. Applications are due by September 1, 2023.

Please contact Sonia Kim at sonia.kim@northwestern.edu or Kali Arduini at karduini@nm.org.

Pictured above, Anna Lisa Somera, CEO of Rhaeos, shares her entrepreneurial journey. CEOs Khalid Ahmed (Stemloop) and Jay Rosenelli (Syenex) also participated in sharing their stories as well.

Pictured above, Summer Scholar Henry Schirmer (McC BS/MS '24) works at a biosafety cabinet in the lab of Opera Bioscience.

2024 INVO PRACTICUM APPLICATION NOW OPEN

The INVO Practicum is an unpaid eight-month internship program (October through May) open to Northwestern graduate students and post-docs who are interested in learning about the university technology transfer process. Upon inquiry, rising undergraduate seniors who exhibit advanced STEM and/or business acumen through coursework or experience may now be considered for the internship as well.

Interns are exposed to vast areas of innovation and gain hands-on experience in evaluating technologies for patentability, marketability and commercialization readiness. They are expected to manage the analysis of multiple technologies that fall in and outside of their wheelhouse and to communicate their findings with INVO staff and faculty inventors. Applications will close on Friday, September 1, 2023.

EXECUTIVES-IN-RESIDENCE

The Querrey InQbation Lab is piloting one-week executive residencies on a (bi)monthly basis that embed seasoned executives in the Northwestern community. The goal is to equip Northwestern faculty and startups with new perspectives, broader networks, and actionable recommendations in their approach to next steps of derisking or commercialization. The first year of programming (Fall 2023) will focus on: Sustainability, Health Data, and Therapeutics. For more information, contact Sonia Kim (sonia.kim@northwestern.edu).



InQbation Lab Summer Scholars| Demo Day

*Invitation Only*

Event to show case our Summer Scholars Program

Friday, August 4, 2023 | 11 AM - 2 PM

OUP| Setting Up Boards For Your Startup

Bob Adelson, Managing Partner OUP

Bill Harrington, Managing Partner OUP

Wednesday, August 23, 2023 | 11 AM - 12:15 PM (remote)



More Details

CHICAGO BIOCAPITAL SUMMIT

Chicago BioCapital Summit will bring together cutting-edge programs and/or startups and connect them with a national audience of VCs. Coordinated by the Chicago Biomedical Consortium, in partnership with Northwestern University, the University of Chicago, and the University of Illinois Chicago, the BioCapital will take place on November 2, 2023 in downtown Chicago. For registration details, visit the registration page here.  

INTERNATIONAL TOP-DOWN PROTEOMICS SYMPOSIUM

Northwestern’s Chemistry of Life Processes Institute will host the second International Top Down Proteomics Symposium, October 3-5, 2023 at Northwestern Medicine’s Prentice Women’s Hospital. Leading experts in the field will discuss groundbreaking technologies and approaches for the analysis of human proteins that are advancing precision medicine. Details may be found here.  

If you have any questions, please visit the Querrey InQbation Lab or email inQbationlab@northwestern.edu.